PDF(1091 KB)
Clinical effect of double filtration plasmapheresis combined with glucocorticoid and immunosuppressant in treatment of children with severe Henoch-Schönlein purpura nephritis
LIU Na, MA Zhong-Zheng, YAN Hui-Fang, LI Qiong, LYU Xiao-Qian, KANG Wei-Li, YIN Zhan-Ru
Chinese Journal of Contemporary Pediatrics ›› 2019, Vol. 21 ›› Issue (10) : 955-959.
PDF(1091 KB)
PDF(1091 KB)
Clinical effect of double filtration plasmapheresis combined with glucocorticoid and immunosuppressant in treatment of children with severe Henoch-Schönlein purpura nephritis
Objective To study the clinical effect and safety of double filtration plasmapheresis (DFPP) combined with double pulse therapy with methylprednisolone (MP) and cyclophosphamide (CTX) in the treatment of children with severe Henoch-Schönlein purpura nephritis (HSPN). Methods A total of 60 children with severe HSPN who were admitted to the hospital from January 2014 to March 2018 were enrolled and were randomly divided into an observation group and a control group (n=30 each). In addition to routine treatment, the children in the control group were given MP+CTX pulse therapy. Those in the observation group were given DFPP treatment in addition to the treatment in the control group, with three courses of treatment in total. After three courses of treatment, the two groups were compared in terms of 24-hour urinary protein, urinary microproteins, renal function parameters, adverse reactions, and clinical outcome. Results After three courses of treatment, the observation group had significantly greater reductions in 24-hour urinary protein, urinary albumin, urinary immunoglobulin G, urinary β2-microglobulin, serum creatinine, and blood urea nitrogen than the control group (P < 0.05). After the treatment ended, the observation group had a significantly shorter time to achieve remission than the control group (P < 0.05). No serious adverse reactions, such as hemorrhagic cystitis, thrombocytopenia, and hemolysis, were observed, and there was no significant difference in the overall incidence rate of adverse reactions between the two groups (P > 0.05). Conclusions Compared with MP+CTX pulse therapy alone in the treatment of severe HSPN in children, DFPP combined with MP+CTX pulse therapy can further alleviate renal injury and improve clinical outcome and does not increase the incidence rate of adverse reactions.
Henoch-Schönlein purpura nephritis / Double filtration plasmapheresis / Methylprednisolone / Cyclophosphamide / Child
[1] Sun L, Xie B, Zhang Q, et al. Biomarkers identification by a combined clinical and metabonomics analysis in HenochSchönlein purpura nephritis children[J]. Oncotarget, 2017, 8(69):114239-114250.
[2] 中华医学会儿科学分会肾脏病学组.儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行)[J].中华儿科杂志, 2009, 47(12):911-914.
[3] Yuan L, Wang Q, Zhang S, et al. Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schönlein purpura with renal function impairment[J]. Exp Ther Med, 2018, 15(4):3924-3928.
[4] 张焱,许煊,祝彬,等.血浆置换在儿童危重自身免疫性疾病中的应用[J].中国急救复苏与灾害医学杂志, 2014, 9(6):497-499.
[5] 程江,王丽峰,宋晓翔,等.甲基泼尼松龙联合环磷酰胺冲击治疗重症紫癜性肾炎18例疗效观察[J].临床儿科杂志, 2009, 27(10):979-981.
[6] Hirano K, Amano H, Kawamura T, et al. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification[J]. Clin Exp Nephrol, 2016, 20(3):425-432.
[7] 蔡青青,解新芳,李晓萍,等.新月体IgA肾病与新月体过敏性紫癜肾炎的临床病理及预后分析[J].中华肾脏病杂志, 2016, 32(11):801-804.
[8] Kang Z, Li Z, Duan C, et al. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children[J]. Pediatr Nephrol, 2015, 30(7):1121-1129.
[9] Sekine A, Hasegawa E, Hiramatsu R, et al. Two types of renovascular lesions in lupus nephritis with clinical thrombotic thrombocytopenic purpura[J]. Case Rep Nephrol Dial, 2015, 5(3):192-199.
[10] 廖柳华,林俊荣,卢莉敏.大剂量环磷酰胺联合甲基泼尼龙冲击治疗小儿过敏性紫癜性肾炎的效果观察[J].内蒙古医学杂志, 2016, 48(8):982-983.
[11] Hoshino J, Fujii T, Usui J, et al. Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy:results of a multicenter cohort study[J]. Clin Exp Nephrol, 2016, 20(4):618-627.
[12] Iwazu Y, Akimoto T, Izawa S, et al. Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy[J]. Clin Exp Nephrol, 2012, 16(3):485-489.
[13] 梁文学,尹良红,陈湛华,等.双重滤过血浆置换治疗血栓性血小板减少性紫癜/溶血尿毒症综合征一例[J].中华肾脏病杂志, 2013, 29(11):875-876.
[14] 林倩,毛建华.儿童重症紫癜性肾炎的治疗及预后[J].国际儿科学杂志, 2019, 46(1):10-13.
[15] 陈海燕,邬步云,徐斌,等.双重血浆置换治疗中血清致病抗体清除效率与疗效的关系[J].肾脏病与透析肾移植杂志, 2014, 23(3):235-238.
[16] Zhang YY, Tang Z, Chen DM, et al. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis[J]. BMC Nephrol, 2014, 15:128.
[17] Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone[J]. Pediatr Nephrol, 2007, 22(8):1167-1171.
[18] Lee J, Clayton F, Shihab F, et al. Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft with plasmapheresis[J]. Am J Transplant, 2008, 8(1):228-231.
[19] 李晶.血浆置换联合激素治疗过敏性紫癜的疗效观察[J].中国现代药物应用, 2011, 5(11):6-7.
